<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35080131</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>03</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>03</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1757-5672</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>14</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>Lower urinary tract symptoms</Title>
          <ISOAbbreviation>Low Urin Tract Symptoms</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Freeflow: The novel portable uroflowmeter can help to realize practical urinary conditions at home.</ArticleTitle>
        <Pagination>
          <StartPage>208</StartPage>
          <EndPage>213</EndPage>
          <MedlinePgn>208-213</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/luts.12426</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To evaluate the effectiveness of a novel portable urine flowmeter, Freeflow, for examining the actual state of urination at home.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Forty-three patients with benign prostatic hyperplasia used the Freeflow uroflowmeter in the hospital and at home without accumulating urine. We created a nomogram for each patient's urine volume and maximal urinary flow rate (Qmax). Furthermore, we investigated the actual state of each patient's urination. We also investigated the differences in the micturition status between daytime and nighttime.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 43 patients, 40 were able to provide the necessary data in the hospital, and all patients provided data measured at home. The trial period of the home assessment was 2-7 days. Regarding the average urine volume, no significant difference was observed between in-hospital and at-home patients; however, Qmax and mean flow rate (Qave) were significantly higher at home. The average coefficient of variation was very large. The relationship between daytime and nighttime was observed in 30 patients; urine volume increased significantly at nighttime; however, no significant difference was observed in Qmax and Qave. The nomogram for several days and a completed urinary diary helped to display daytime and nighttime urination characteristics.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Freeflow, the newly developed uroflowmeter, enabled us to determine the fluctuations in the measurements recorded at home and the differences between daytime and nighttime. Thus, creating a nomogram for objectively examining nighttime urination status and utilizing a urination diary was found to be effective for providing correct diagnosis and treatment of lower urinary tract symptoms.</AbstractText>
          <CopyrightInformation>© 2022 John Wiley &amp; Sons Australia, Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kato</LastName>
            <ForeName>Shinobu</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Cooperation Kato Urological Clinic, Hiratsuka, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Watanabe</LastName>
            <ForeName>Hajime</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Cooperation Kato Urological Clinic, Hiratsuka, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yamasue</LastName>
            <ForeName>Kotaro</ForeName>
            <Initials>K</Initials>
            <Identifier Source="ORCID">0000-0003-4974-3211</Identifier>
            <AffiliationInfo>
              <Affiliation>Public Health and Preventive Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>01</Month>
          <Day>25</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Australia</Country>
        <MedlineTA>Low Urin Tract Symptoms</MedlineTA>
        <NlmUniqueID>101506777</NlmUniqueID>
        <ISSNLinking>1757-5664</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D045268" MajorTopicYN="Y">Flowmeters</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059411" MajorTopicYN="Y">Lower Urinary Tract Symptoms</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011470" MajorTopicYN="Y">Prostatic Hyperplasia</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014554" MajorTopicYN="N">Urination</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014555" MajorTopicYN="Y">Urination Disorders</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014563" MajorTopicYN="N">Urodynamics</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">LUTS</Keyword>
        <Keyword MajorTopicYN="N">nomogram</Keyword>
        <Keyword MajorTopicYN="N">portable uroflowmeter</Keyword>
        <Keyword MajorTopicYN="N">urination diary</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>7</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>26</Day>
          <Hour>5</Hour>
          <Minute>34</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35080131</ArticleId>
        <ArticleId IdType="doi">10.1111/luts.12426</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>van Venrooij GE, Eckartdt MD, Boon TA. Noninvasive assessment of prostatic obstruction in elderly men with lower urinary symptoms associated with benign prostatic hyperplasia. Urology. 2004;63:476-480. doi:10.1016/j.urology.2003.10.021</Citation>
        </Reference>
        <Reference>
          <Citation>Bray A, Griffiths C, Drinnan M, Pickard R. Methods and value of home uroflowmetry in the assessment of men with lower urinary tract symptoms: a literature review. Neurourol Urodyn. 2012;31:7-12. doi:10.1002/nau.21197</Citation>
        </Reference>
        <Reference>
          <Citation>Chun K, Kim SJ, Cho ST. Noninvasive medical tools for evaluating voiding pattern in real life. Int Neurourol J. 2017;21(suppl 1):S10-S16. doi:10.5213/inj.1734860.430</Citation>
        </Reference>
        <Reference>
          <Citation>Jørgensen JB, Jacobsen HL, Bagi P, Hvarnes H, Colstrup H. Home uroflowmetry by means of the Da capo home uroflowmeter. Eur Urol. 1998;33:64-68. doi:10.1159/000019534</Citation>
        </Reference>
        <Reference>
          <Citation>Porru D, Scarpa RM, Prezioso D, Bertaccini A, Rizzi CA, HOUSE Study Group. Home and office uroflowmetry for evaluation of LUTS from benign prostatic enlargement. Prostate Cancer Prostatic Dis. 2005;8:45-49. doi:10.1038/sj.pcan.4500763</Citation>
        </Reference>
        <Reference>
          <Citation>Gammie A, Rosier P, Li R, Harding C. How can we maximize the diagnostic utility of uroflow? Neurourol Urodyn. 2018;37(suppl 4):S20-S24. doi:10.1002/nau.23472</Citation>
        </Reference>
        <Reference>
          <Citation>Heesakkers J, Farag F, Pantuck A, Moore K, Radziszewski P, Lucas M. Applicability of a disposable home urinary flow measuring device as a diagnostic tool in the management of males with lower urinary tract symptoms. Urol Int. 2012;89:166-172. doi:10.1159/000338907</Citation>
        </Reference>
        <Reference>
          <Citation>Pridgeon S, Harding C, Newton D, Pickard R. Clinical evaluation of a simple uroflowmeter for categorization of maximum urinary flow rate. Indian J Urol. 2007;23:114-118. doi:10.4103/0970-1591</Citation>
        </Reference>
        <Reference>
          <Citation>Kato S, Watanabe H, Yamasue K, Shiroki R. Evaluation of home and office uroflowmetry using the newly developed portable uroflowmeter Freeflow™. J Japanese Contin Soc. 2019;30:483-486. (Japanese).</Citation>
        </Reference>
        <Reference>
          <Citation>Siroky MB, Olsson CA, Krane RJ. The flow rate nomogram: I. Development. J Urol. 1979;122:665-668. doi:10.1016/S0022-5347(17)56550-7</Citation>
        </Reference>
        <Reference>
          <Citation>Shimokawa S, Udagawa H, Hara T, JP 6540795 (21 June 2019) WO2016/152847 (Geo-System Co.jp).</Citation>
        </Reference>
        <Reference>
          <Citation>Abu-Yousef MM, Narayana AS. Transabdominal ultrasound in the evaluation of prostate size. J Clin Ultrasound. 1982;10:275-278. doi:10.1002/jcu.1870100606</Citation>
        </Reference>
        <Reference>
          <Citation>Matzkin H, van der Zwaag R, Chen Y, Patterson LA, Brat Z, Soloway MS. How reliable single measurement of urinary flow in the diagnosis of obstruction in benign prostatic hyperplasia? Br J Urol. 1993;72:181-186. doi:10.1111/j.1464-410X.1993.tb00684.x</Citation>
        </Reference>
        <Reference>
          <Citation>Golomb J, Lindner A, Siegel Y, Korczak D. Variability, and circadian changes in home uroflowmetry in patients with benign prostatic hyperplasia compared to normal controls. J Urol. 1992;147:1044-1047. doi:10.1016/S0022-5347(17)37462-1</Citation>
        </Reference>
        <Reference>
          <Citation>Summers SJ, Armstrong JM, Kaplan SA, et al. Male voiding behavior: insight from 19,824 at-home uroflow profiles. J Urol. 2021;205:1126-1132. doi:10.1097/JU.0000000000001504</Citation>
        </Reference>
        <Reference>
          <Citation>Witjes WP, Wijkstra H, Debruyne FM, de la Rosette JJ. Quantitative assessment of uroflow: is there a circadian rhythm? Urology. 1997;50:221-228. doi:10.1016/S0090-4295(97)00190-8</Citation>
        </Reference>
        <Reference>
          <Citation>Ceyhan E, Asutay MK. Standardization for reliable uroflowmetry testing in adults. LUTS. 2021;1:45-50. doi:10.1111/lutz,12323</Citation>
        </Reference>
        <Reference>
          <Citation>Homma Y, Gotoh M, Kawauchi A, et al. Clinical guidelines for male lower urinary tract symptoms and benign prostatic hyperplasia. Int J Urol. 2017;24:716-729. doi:10.1111/iju.13401</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
